| scholarly article | Q13442814 |
| P2093 | author name string | Hao Yang | |
| Wei Zheng | |||
| Lei Yu | |||
| Xiao Shuai | |||
| Feng Fang | |||
| Lian-Yue Yang | |||
| Rui-Min Chang | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| The Ki-67 protein: from the known and the unknown | Q28143714 | ||
| Biology of hepatocellular carcinoma | Q28266656 | ||
| Hepatocellular carcinoma | Q29615841 | ||
| MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. | Q30434790 | ||
| Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung. | Q34167119 | ||
| Molecular mechanisms of E2F-dependent activation and pRB-mediated repression | Q34318740 | ||
| The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells | Q34592870 | ||
| Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma | Q35007692 | ||
| Retracted: MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb | Q35133520 | ||
| TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation | Q35562945 | ||
| Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. | Q36126555 | ||
| Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis | Q36694298 | ||
| Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4. | Q37019606 | ||
| MiR-424/503-mediated Rictor upregulation promotes tumor progression | Q37296909 | ||
| Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells | Q37487108 | ||
| MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers | Q38009600 | ||
| Molecular pathways: microRNAs as cancer therapeutics. | Q38019896 | ||
| MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? | Q38053397 | ||
| MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase | Q38995250 | ||
| Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma | Q39181475 | ||
| MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. | Q39184127 | ||
| MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma | Q39196206 | ||
| Role of the retinoblastoma protein in the pathogenesis of human cancer | Q41639462 | ||
| Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing. | Q42587248 | ||
| p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection | Q43580782 | ||
| Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma | Q46712958 | ||
| MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 | ||
| MicroRNAs in liver disease. | Q51793583 | ||
| Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. | Q51828299 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection | Q83078350 | ||
| Molecular classification of hepatocellular carcinoma | Q84403214 | ||
| MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression | Q84598420 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 27736-27750 | |
| P577 | publication date | 2015-08-03 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma | |
| P478 | volume | 6 |
| Q37472263 | Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison |
| Q41279168 | Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression |
| Q92003250 | Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma |
| Q61449008 | Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma |
| Q53708414 | Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway. |
| Q99630249 | Cyto-biological effects of microRNA-424-5p on human colorectal cancer cells |
| Q36464660 | Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma |
| Q99630344 | Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma |
| Q47405744 | Functional characterization of E2F3b in human HepG2 liver cancer cell line. |
| Q64235110 | Genome-wide DNA methylation profiles in Tibetan and Yorkshire pigs under high-altitude hypoxia |
| Q49203051 | HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells |
| Q64914155 | Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database. |
| Q91789437 | LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis |
| Q51474565 | Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer. |
| Q92134710 | Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer |
| Q51639014 | MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy. |
| Q37295313 | MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1 |
| Q38784189 | MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation |
| Q37588270 | MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1 |
| Q41694299 | MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers |
| Q55054667 | MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation. |
| Q90397975 | MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues |
| Q40923110 | PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs |
| Q47096853 | Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis |
| Q64228137 | Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma |
| Q47198207 | SEGreg: a database for human specifically expressed genes and their regulations in cancer and normal tissue |
| Q96304826 | Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance |
| Q48140189 | Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer. |
| Q59800180 | miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer |
Search more.